DECREASING PATTERNS OF INFLIXIMAB TROUGH LEVELS IN ASYMPTOMATIC INFLAMMATORY BOWEL DISEASE PATIENTS UNDER MAINTENANCE TREATMENT WITH INFLIXIMAB; DOES IT MATTER?

被引：0
|
作者：
Orfanoudaki, Eleni
Gazouli, Maria
Foteinogiannopoulou, Kalliopi
Theodoraki, Eirini
Legaki, Evangelia
Koutroubakis, Ioannis E.
机构：
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1890
引用
收藏
页码：S467 / S467
页数：1
相关论文
共 50 条
  • [21] Influence of initial albumin levels on infliximab and adalimumab trough levels in inflammatory bowel disease patients
    Gonzalez-Lopez, J.
    Llamas, C.
    Giraldez-Montero, J. M.
    Ferreiro, R.
    Baston, I.
    Lamas, M. J.
    Dominguez-Munoz, J. E.
    Barreiro-de Acosta, M.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S248 - S249
  • [22] Success and safety of high infliximab trough levels in inflammatory bowel disease
    Drobne, David
    Kurent, Tina
    Golob, Sasa
    Svegl, Polona
    Rajar, Polona
    Terzic, Sara
    Kozelj, Matic
    Novak, Gregor
    Smrekar, Natasa
    Plut, Samo
    Sever, Nejc
    Strnisa, Luka
    Hanzel, Jurij
    Brecelj, Jernej
    Urlep, Darja
    Osredkar, Josko
    Homan, Matjaz
    Orel, Rok
    Stabuc, Borut
    Ferkolj, Ivan
    Smid, Alojz
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2018, 53 (08) : 940 - 946
  • [23] Dosing interval and diagnosis predict infliximab levels in patients with inflammatory bowel disease on maintenance treatment
    Krajcovicova, A.
    Batovsky, M.
    Gregus, M.
    Hlista, M.
    Durina, J.
    Leskova, Z.
    Sturdik, I
    Gojdic, M.
    Jalali, Y.
    Koller, T.
    Toth, J.
    Huorka, M.
    Hlavaty, T.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2018, 81 (04) : 465 - 470
  • [24] The association of infliximab trough levels with disease activity in pediatric inflammatory bowel disease
    Hoekman, Daniel R.
    Brandse, Johannan F.
    de Meij, Tim G.
    Hummel, Thalia Z.
    Lowenberg, Mark
    Benninga, Marc A.
    D'Haens, Geert R.
    Kindermann, Angelika
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2015, 50 (09) : 1110 - 1117
  • [25] Infliximab trough levels are associated with disease activity in pediatric inflammatory bowel disease
    Hoekman, D. R.
    Brandse, J. F.
    de Meij, T. G.
    Hummel, T. Z.
    Lowenberg, M.
    Benninga, M. A.
    D'Haens, G. R. A. M.
    Kindermann, A.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S412 - S412
  • [26] Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease
    Vande Casteele, Niels
    Ferrante, Marc
    Van Assche, Gert
    Ballet, Vera
    Compernolle, Griet
    Van Steen, Kristel
    Simoens, Steven
    Rutgeerts, Paul
    Gils, Ann
    Vermeire, Severine
    GASTROENTEROLOGY, 2015, 148 (07) : 1320 - +
  • [27] Infliximab Trough Levels Are Associated With Transmural Sonographic Healing in Inflammatory Bowel Disease
    Vaughan, Rose
    Murphy, Elise
    Nalder, Michelle
    Gibson, Robert N.
    Ardalan, Zaid
    Boussioutas, Alex
    Christensen, Britt
    INFLAMMATORY BOWEL DISEASES, 2023, 29 (07) : 1080 - 1088
  • [28] Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease
    van Hoeve, Karen
    Dreesen, Erwin
    Hoffman, Ilse
    Van Assche, Gert
    Ferrante, Marc
    Gils, Ann
    Vermeire, Severine
    JOURNAL OF CROHNS & COLITIS, 2018, 12 (11): : 1316 - 1325
  • [29] Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
    Theodoraki, Eirini
    Orfanoudaki, Eleni
    Foteinogiannopoulou, Kalliopi
    Legaki, Evangelia
    Gazouli, Maria
    Koutroubakis, Ioannis E.
    INTESTINAL RESEARCH, 2021, 19 (04) : 461 - 467
  • [30] SERUM INFLIXIMAB TROUGH LEVELS ARE NOT ASSOCIATED WITH ACTIVE PERIPHERAL ARTHRALGIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Sekhri, Shaina
    Rao, Bharat
    Mohananey, Akanksha
    Beniwal-Patel, Poonam
    Stein, Daniel J.
    Yarur, Andres J.
    GASTROENTEROLOGY, 2021, 160 (06) : S693 - S694
12345